We are proud to share that Axent Bio has received multiple Small Business Innovation Research (SBIR) awards from the National Institutes of Health (NIH).
These awards support the development of our thermoreversible 3D gel encapsulation platform, enabling scalable, robust, and clinically relevant solutions for cell therapy manufacturing.
We’re grateful for NIH’s support and look forward to sharing further progress as we continue to build the future of cell-based therapeutics.
